LYSMD4

Model summary

A secreted and membrane-associated human adaptor that uses a central LysM module to organize transient protein assemblies controlling gene expression and protein turnover. By assembling transcriptional regulators and proteostasis machinery, it can both enhance and repress RNA polymerase II–dependent transcription and promote proteasome-driven degradation. Its biosynthetic itinerary through the Golgi and delivery to the cell surface, together with release into extracellular fluids, position it at membrane-proximal and secretory interfaces where it senses and relays signals to nuclear and cytoplasmic regulatory hubs.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The polypeptide carries a central LysM module: IPR018392 (LysM domain, residues 74–119) sits within IPR036779 (LysM domain superfamily, residues 75–124), and the entire protein is classified by IPR045030 (LysM and putative peptidoglycan-binding domain-containing protein 1–4 family, residues 7–246). This arrangement places a canonical LysM fold in the middle of the sequence, a fold classically used for carbohydrate- or polymer-recognition but broadly repurposed in eukaryotes for protein–protein and matrix interactions. The single LysM core flanked by extended regions suggests a non-enzymatic adaptor that binds macromolecular partners rather than catalyzing reactions. This architecture causally supports a binding-centric molecular function, aligning with GO:0005515 protein binding.

2. 02

   From this binding-centric core, I infer how the protein exerts regulatory control over transcription and protein turnover.

   The LysM fold provides a compact interaction hub that can recruit transcriptional regulators and chromatin-associated factors. Such recruitment explains modulation of RNA polymerase II outputs in both directions: it can enhance assembly or stability of transcriptional complexes (GO:0045893 positive regulation of DNA-templated transcription) while also assembling repressor modules that dampen expression of specific loci (GO:0000122 negative regulation of transcription by RNA polymerase II). The same interaction scaffold can couple to ubiquitin–proteasome pathways by docking E3 ligases or shuttle factors, thereby accelerating degradation of selected substrates; this mechanism accounts for GO:2000060 positive regulation of proteasomal protein catabolic process.

3. 03

   Cellular localization follows from the trafficking and regulatory logic.

   The presence of a secreted form and a membrane-associated pool indicates a signal peptide–driven secretory route with transient residence in the Golgi apparatus (GO:0005794) and delivery to the plasma membrane (GO:0005886). Secreted pools in extracellular vesicles and body fluids are consistent with a soluble adaptor that can be released, while membrane-associated fractions likely arise from co-translational targeting and retention motifs. Together, these localizations position the protein at membrane-proximal and secretory interfaces where it can sample extracellular cues and relay them to nuclear transcriptional programs.

4. 04

   Mechanistically, I propose that the LysM module nucleates transient complexes that tune transcription and proteostasis.

   At the plasma membrane and along the Golgi, the protein binds glycoprotein-rich surfaces and trafficking machinery, then shuttles to intracellular hubs to assemble transcriptional and ubiquitin–proteasome modules. This dual-compartment cycle explains how a single-domain adaptor can both stimulate and restrain RNA polymerase II–dependent transcription and enhance proteasomal turnover. Likely interaction partners include chromatin remodelers and transcriptional co-regulators that set promoter competence; E3 ubiquitin ligases and proteasome adaptors that elevate substrate flux; and membrane/secretory pathway components that guide its trafficking and secretion. These partnerships collectively produce a versatile regulatory node coordinating gene expression with protein degradation and extracellular signaling.